![Anthony S. Chilton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Anthony S. Chilton
Former positions of Anthony S. Chilton
Companies | Position | Start | End |
---|---|---|---|
INOTIV, INC. | Director/Board Member | 14/02/2011 | 02/03/2012 |
Corporate Officer/Principal | 01/12/2008 | 28/01/2010 | |
President | 28/01/2010 | 05/07/2012 | |
CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01/01/1998 | - |
Genmedica Therapeutics SL
![]() Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | 22/03/2010 | - |
Training of Anthony S. Chilton
University of East Anglia | Undergraduate Degree |
University of Hertfordshire | Doctorate Degree |
Statistics
International
United States | 3 |
United Kingdom | 3 |
Spain | 2 |
Operational
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
President | 1 |
Sectoral
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
INOTIV, INC. | Commercial Services |
CARDINAL HEALTH, INC. | Distribution Services |
Private companies | 1 |
---|---|
Genmedica Therapeutics SL
![]() Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
- Stock Market
- Insiders
- Anthony S. Chilton
- Experience